<p>Antibody immunoreactivity was analyzed by <i>assay type</i> for each HCV antigen. Two categories are presented: neutralizing assays (standard neutralization assays or any inhibition of antigen activity assay) and other antibody response assays (ELISA, FIA, ELISPOT, immunoblot, RIA, SPR, Immunopanning, mass spec, challenge assay, etc.). Data shown are the total number of assays, not epitopes.</p
<p>Reactivities and epitope mapping of monoclonal antibodies (mAbs) against HCV-LPs of genotypes 3a ...
There is a need for simple to produce immunoassays for Hepatitis C Virus (HCV) antibody capable of d...
<p>Plates were coated with purified soluble E1 or E2 glycoprotein or NS3 of HCV as antigen to detect...
Abstract Background All commercial Hepatitis C virus antibody (anti-HCV) assays use a combination of...
Background/Aim. The role of humoral immunity in hepatitis C virus (HCV) infection is poorly understo...
Hepatitis C virus (HCV) infection is a major global public health problem. Early induction of cross-...
BACKGROUND: There is little information on the timing, magnitude, specificity, and clinical relevanc...
Hepatitis C is one of the leading causes of hepatocellular carcinoma and remains at a high prevalenc...
We tested serum samples from blood donors by using first-, second-, and third-generation enzyme immu...
Hepatitis C virus (HCV) infection is a major global health problem. In the majority of cases the vir...
Hepatitis C virus (HCV) infection is a major global health problem. In the majority of cases the vir...
Objective To determinate the prevalence of 5 neutralization epitope-binding antibodies and their cro...
Background: Development of “combination” assays detecting in parallel, within a single test, Hepatit...
Approximately 3 % of the world population is infected by HCV, which represents a major global health...
International audienceAntibody responses to the hepatitis C virus (HCV) envelope proteins E1 and E2 ...
<p>Reactivities and epitope mapping of monoclonal antibodies (mAbs) against HCV-LPs of genotypes 3a ...
There is a need for simple to produce immunoassays for Hepatitis C Virus (HCV) antibody capable of d...
<p>Plates were coated with purified soluble E1 or E2 glycoprotein or NS3 of HCV as antigen to detect...
Abstract Background All commercial Hepatitis C virus antibody (anti-HCV) assays use a combination of...
Background/Aim. The role of humoral immunity in hepatitis C virus (HCV) infection is poorly understo...
Hepatitis C virus (HCV) infection is a major global public health problem. Early induction of cross-...
BACKGROUND: There is little information on the timing, magnitude, specificity, and clinical relevanc...
Hepatitis C is one of the leading causes of hepatocellular carcinoma and remains at a high prevalenc...
We tested serum samples from blood donors by using first-, second-, and third-generation enzyme immu...
Hepatitis C virus (HCV) infection is a major global health problem. In the majority of cases the vir...
Hepatitis C virus (HCV) infection is a major global health problem. In the majority of cases the vir...
Objective To determinate the prevalence of 5 neutralization epitope-binding antibodies and their cro...
Background: Development of “combination” assays detecting in parallel, within a single test, Hepatit...
Approximately 3 % of the world population is infected by HCV, which represents a major global health...
International audienceAntibody responses to the hepatitis C virus (HCV) envelope proteins E1 and E2 ...
<p>Reactivities and epitope mapping of monoclonal antibodies (mAbs) against HCV-LPs of genotypes 3a ...
There is a need for simple to produce immunoassays for Hepatitis C Virus (HCV) antibody capable of d...
<p>Plates were coated with purified soluble E1 or E2 glycoprotein or NS3 of HCV as antigen to detect...